James N. Clarke
Listed on 1 Form D filing across 1+ issuer
· Director
Associated issuers
- Biolexis Therapeutics Inc. CIK 1914060 · UT
Filings (1)
-
Biolexis Therapeutics Inc.D · Jun 3, 2026 · UT · Biotechnology$12MView filing →